LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAD0. A total of 18 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 2.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,193,000 | -92.9% | 0 | -100.0% | 0.00% | -93.8% |
| Q2 2016 | $30,941,000 | +34.9% | 18,500,000 | +23.3% | 0.06% | +30.0% |
| Q1 2016 | $22,940,000 | -13.8% | 15,000,000 | -12.8% | 0.05% | -18.0% |
| Q4 2015 | $26,617,000 | +40.6% | 17,200,000 | +18.6% | 0.06% | +35.6% |
| Q3 2015 | $18,931,000 | – | 14,500,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINDEN ADVISORS LP | 41,855,000 | $69,957,000 | 3.06% |
| Myriad Asset Management Ltd. | 20,000,000 | $33,349,000 | 2.89% |
| TFG Asset Management GP Ltd | 6,000,000 | $10,022,000 | 2.28% |
| BASSO CAPITAL MANAGEMENT, L.P. | 8,425,000 | $14,058,000 | 2.18% |
| Opera Trading Capital | 3,700,000 | $6,178,000 | 1.34% |
| CAMDEN ASSET MANAGEMENT L P /CA | 22,575,000 | $37,644,000 | 1.29% |
| Man Investments (CH) AG | 1,000,000 | $1,668,000 | 0.87% |
| Verition Fund Management LLC | 3,200,000 | $5,352,000 | 0.68% |
| WOLVERINE ASSET MANAGEMENT LLC | 24,445,000 | $40,849,000 | 0.62% |
| PALISADE CAPITAL MANAGEMENT, LP | 4,800,000 | $8,014,000 | 0.29% |